Document is current
Any future updates will be listed below
-
Authors
Swoboda, Ryszard https://orcid.org/0000-0002-5897-3919
Labopin, Myriam https://orcid.org/0000-0003-4514-4748
Kröger, Nicolaus
Stelljes, Matthias https://orcid.org/0000-0002-9331-5145
Schroeder, Thomas
Dreger, Peter https://orcid.org/0000-0002-7429-8570
Bug, Gesine https://orcid.org/0000-0003-2359-131X
McDonald, Andrew
Özçelik, Tülay
Rovira, Montserrat
Blau, Igor Wolfgang
Kunadt, Desiree https://orcid.org/0000-0001-8750-5308
Peffault de Latour, Régis
Rabitsch, Werner
Eder, Matthias https://orcid.org/0009-0000-3362-5814
Rubio, Marie Therese https://orcid.org/0000-0003-3732-5442
Spyridonidis, Alexandros https://orcid.org/0000-0003-3097-2532
Peric, Zinaida https://orcid.org/0000-0001-9458-8025
Giebel, Sebastian
Mohty, Mohamad https://orcid.org/0000-0002-7264-808X
Ciceri, Fabio https://orcid.org/0000-0003-0873-0123
- License Information
-
More Information
Article History
Received: 15 March 2026
Revised: 8 May 2026
Accepted: 3 June 2026
First Online: 8 July 2026
Ethics
Competing interests: GB has received honoraria from Novartis, Jazz, BMS and Gilead and travel grants from Jazz, Gilead and Neovii. Other authors declare that they have no competing interests.
Ethics approval and consent to participate: The study was approved by the ALWP of the EBMT institutional review board and conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Informed consent was obtained from all subjects.
